Agilent Technologies Inc (NYSE:A) – Jefferies Financial Group lowered their FY2019 EPS estimates for Agilent Technologies in a report issued on Wednesday, May 15th. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will post earnings per share of $3.06 for the year, down from their prior estimate of $3.07.

Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The company’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the business earned $0.65 EPS.

A number of other research analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a report on Monday, January 21st. Deutsche Bank raised their price target on shares of Agilent Technologies from $80.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, February 12th. Robert W. Baird restated a “buy” rating and set a $82.00 price target (up previously from $77.00) on shares of Agilent Technologies in a report on Wednesday, February 20th. JPMorgan Chase & Co. raised their price target on shares of Agilent Technologies to $85.00 and gave the company an “overweight” rating in a report on Thursday, February 21st. Finally, Barclays raised their price target on shares of Agilent Technologies from $80.00 to $83.00 and gave the company an “overweight” rating in a report on Thursday, February 21st. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and an average target price of $86.58.

Shares of NYSE:A opened at $69.11 on Friday. The firm has a market cap of $22.00 billion, a price-to-earnings ratio of 24.77, a P/E/G ratio of 1.93 and a beta of 1.33. Agilent Technologies has a 12-month low of $60.42 and a 12-month high of $82.27. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.79.

A number of institutional investors and hedge funds have recently made changes to their positions in A. Captrust Financial Advisors increased its holdings in shares of Agilent Technologies by 2,121.1% during the 4th quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after purchasing an additional 403 shares during the period. Lake Point Wealth Management bought a new position in shares of Agilent Technologies during the 4th quarter worth about $30,000. JOYN Advisors Inc. increased its holdings in shares of Agilent Technologies by 186.6% during the 4th quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after purchasing an additional 306 shares during the period. Destination Wealth Management increased its holdings in shares of Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, We Are One Seven LLC bought a new position in shares of Agilent Technologies during the 4th quarter worth about $33,000.

In related news, VP Rodney Gonsalves sold 6,155 shares of Agilent Technologies stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $79.79, for a total value of $491,107.45. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Mark Doak sold 16,421 shares of Agilent Technologies stock in a transaction on Friday, February 22nd. The stock was sold at an average price of $77.95, for a total transaction of $1,280,016.95. The disclosure for this sale can be found here. Insiders sold a total of 48,583 shares of company stock worth $3,855,924 in the last quarter.

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd were issued a $0.164 dividend. The ex-dividend date of this dividend was Monday, April 1st. This represents a $0.66 annualized dividend and a yield of 0.95%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Channel Trading

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.